Xujun Zhang
Overview
Explore the profile of Xujun Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
717
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang J, Feng J, Kang Y, Pan P, Ge J, Wang Y, et al.
Sci Adv
. 2025 Mar;
11(10):eads8932.
PMID: 40043127
Large language models (LLMs) have shown remarkable advancements in chemistry and biomedical research, acting as versatile foundation models for various tasks. We introduce AMP-Designer, an LLM-based approach, for swiftly designing...
2.
Li C, Du H, Zhang C, Huang W, Zhang X, Wang T, et al.
J Chem Inf Model
. 2025 Jan;
65(4):2014-2025.
PMID: 39888349
Deoxyribonucleic acid (DNA) serves as a repository of genetic information in cells and is a critical molecular target for various antibiotics and anticancer drugs. A profound understanding of small molecule...
3.
Padilla M, Padilla M, Shepherd S, Hanna A, Kurnik M, Zhang X, et al.
bioRxiv
. 2025 Jan;
PMID: 39763759
Lipid nanoparticles (LNPs) are the most advanced delivery system currently available for RNA therapeutics. Their development has accelerated since the success of Patisiran, the first siRNA-LNP therapeutic, and the mRNA...
4.
Zhang X, Hicks D, Liu H, Glover N, Zhang Z, Grant A, et al.
Rev Sci Instrum
. 2024 Dec;
95(12).
PMID: 39718407
Well-constructed instruments may continue to perform beyond their manufacturer-supported service lifetime, which is typically limited by computer operating system compatibility or the availability of spare parts. Often, such equipment is...
5.
Zhang O, Huang Y, Chen S, Yu M, Zhang X, Lin H, et al.
Chem Sci
. 2024 Dec;
16(3):1467.
PMID: 39713761
[This corrects the article DOI: 10.1039/D4SC04620J.].
6.
Zhang O, Huang Y, Cheng S, Yu M, Zhang X, Lin H, et al.
Chem Sci
. 2024 Nov;
15(46):19452-19465.
PMID: 39568888
3D structure-based molecular generation is a successful application of generative AI in drug discovery. Most earlier models follow an atom-wise paradigm, generating molecules with good docking scores but poor molecular...
7.
Ma J, Su L, Li M, Sheng J, Liu F, Zhang X, et al.
Children (Basel)
. 2024 Oct;
11(10).
PMID: 39457159
Cyberbullying is an increasingly serious issue that negatively impacts the mental and physical health of adolescents. This study aims to report the prevalence rates of adolescent cyberbullying-victimization and its associated...
8.
Du H, Zhang X, Wu Z, Zhang O, Gu S, Wang M, et al.
Nucleic Acids Res
. 2024 Oct;
53(D1):D1322-D1327.
PMID: 39441070
The rational design of targeted covalent inhibitors (TCIs) has emerged as a powerful strategy in drug discovery, known for its ability to achieve strong binding affinity and prolonged target engagement....
9.
Yang Y, Chen G, Li J, Li J, Zhang O, Zhang X, et al.
Commun Biol
. 2024 Sep;
7(1):1074.
PMID: 39223327
Target-aware drug discovery has greatly accelerated the drug discovery process to design small-molecule ligands with high binding affinity to disease-related protein targets. Conditioned on targeted proteins, previous works utilize various...
10.
Sheng J, Yang Y, Lin P, Xiao Y, Sun Y, Fei G, et al.
J Affect Disord
. 2024 Aug;
365:518-526.
PMID: 39191314
Background: Research on the associations of type-specific bullying victimization and poly-bullying victimization with suicidal ideation is limited and contradictory. This study aimed to examine these associations among school-aged adolescents. Methods:...